CoreAge Rx: Non-Hormonal Menopause, oral paroxetine offerChecked 2026-09-27

Provider product information

Read the original source ↗

Checked 2026-09-27. Labels and commercial information can change.

DailyMed: Brisdelle paroxetine capsules, updated April 28, 2025Checked 2026-09-27

Exact product labeling

Read the original source ↗

Checked 2026-09-27. Labels and commercial information can change.

FDA: Understanding unapproved use of approved drugsChecked 2026-09-27

Regulator explanation

Read the original source ↗

Checked 2026-09-27. Labels and commercial information can change.

FDA: Lynkuet drug trials snapshot, approved October 24, 2025Checked 2026-09-27

Regulator approval and trial summary

Read the original source ↗

Checked 2026-09-27. Labels and commercial information can change.

FDA: Veozah serious liver injury safety communicationChecked 2026-09-27

Regulator safety communication

Read the original source ↗

Checked 2026-09-27. Labels and commercial information can change.

DailyMed: Veozah prescribing information, updated February 26, 2026Checked 2026-09-27

Exact product labeling

Read the original source ↗

Checked 2026-09-27. Labels and commercial information can change.

The Menopause Society: 2023 nonhormone therapy position statement, accessible abstractChecked 2026-09-27

Medical society position statement abstract

Read the original source ↗

Checked 2026-09-27. Labels and commercial information can change.

Midi: Menopause care and hormonal/nonhormonal optionsChecked 2026-09-27

Provider service information

Read the original source ↗

Checked 2026-09-27. Labels and commercial information can change.

Midi: Pricing and insuranceChecked 2026-09-27

Provider pricing and access

Read the original source ↗

Checked 2026-09-27. Labels and commercial information can change.

Midi: Additional Medicare and Medicaid access conditionsChecked 2026-09-27

Provider access terms

Read the original source ↗

Checked 2026-09-27. Labels and commercial information can change.

Midi: Non-Hormonal Treatment for Menopause, October 30, 2025Checked 2026-09-27

Provider educational article

Read the original source ↗

Checked 2026-09-27. Labels and commercial information can change.

Evernow: Paroxetine service and product FAQChecked 2026-09-27

Provider product information

Read the original source ↗

Checked 2026-09-27. Labels and commercial information can change.

Evernow: Veozah service and safety summaryChecked 2026-09-27

Provider product information

Read the original source ↗

Checked 2026-09-27. Labels and commercial information can change.

Evernow: Nonhormonal treatment category and FAQChecked 2026-09-27

Provider service information

Read the original source ↗

Checked 2026-09-27. Labels and commercial information can change.

Evernow: Care formats, membership prices, insurance and pharmacy FAQChecked 2026-09-27

Provider terms and pricing

Read the original source ↗

Checked 2026-09-27. Labels and commercial information can change.

Bayer: Lynkuet US prescribing information, revised August 2026Checked 2026-09-27

Current US prescription product labeling

Read the original source ↗

Checked 2026-09-27. Labels and commercial information can change.

The Menopause Society: 2023 nonhormone therapy position statementChecked 2026-09-27

Medical society evidence review

Read the original source ↗

Checked 2026-09-27. Labels and commercial information can change.

The Menopause Society: Hot FlashesChecked 2026-09-27

Medical society patient information

Read the original source ↗

Checked 2026-09-27. Labels and commercial information can change.

FDA: Menopause treatment questionsChecked 2026-09-27

Federal regulator patient information

Read the original source ↗

Checked 2026-09-27. Labels and commercial information can change.

Alloy: ParoxetineChecked 2026-09-29

Official 10 mg offer; FDA-approved wording is not independently applied to the advertised preparation, and one-month/three-month supply wording remains unresolved

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

DailyMed: Brisdelle paroxetine capsulesChecked 2026-09-29

Exact oral 7.5 mg capsule label updated April 28, 2025; approved vasomotor indication and warnings remain product-specific, not Alloy 10 mg authentication

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

FDA: Understanding unapproved use of approved drugsChecked 2026-09-29

Federal explanation distinguishing an approved medicine from an unapproved use; not a personal recommendation

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Alloy: terms of useChecked 2026-09-28

Dated platform terms; subscription and shipment cancellation deadlines, first-shipment refund conditions and service-fee exclusions kept separate

Read the original source ↗

Checked 2026-09-28. Labels and commercial information can change.

Gennev: Symptoms and TreatmentChecked 2026-09-29

Official clinical service and treatment categories; exact nonhormonal medicine selection unconfirmed

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

The Menopause Society: 2023 nonhormone therapy position statementChecked 2026-09-29

PubMed primary professional abstract; vasomotor-symptom evidence categories, dated 2023 and not provider-specific efficacy or later-drug approval

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Gennev: insurance and pricingChecked 2026-09-28

Dated provider fee table and coverage process; doctor/dietitian initial/follow-up costs are separate from pharmacy charges

Read the original source ↗

Checked 2026-09-28. Labels and commercial information can change.

MyMenopauseRx: TreatmentsChecked 2026-09-29

Official clinical offer names fezolinetant and other treatment categories; no personal prescription or outcome confirmed

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

DailyMed: Veozah fezolinetant tabletsChecked 2026-09-29

Exact label revised February 2026 with boxed hepatotoxicity warning, required clinical monitoring and product-specific contraindications; not personal clearance

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

MyMenopauseRx: telehealth FAQChecked 2026-09-28

Dated provider visit/pharmacy/refill/coverage/cancellation record; personal prescription, generic identity and clinical decisions remain unverified

Read the original source ↗

Checked 2026-09-28. Labels and commercial information can change.

Pandia Health: Menopause careChecked 2026-09-29

Official current clinical/pharmacy menu includes paroxetine and Veozah; pharmacy stock, selected medicine and malformed three-month billed amount unresolved

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Stella US: Menopause careChecked 2026-09-29

US clinical offer, age/access and payment information; nonhormonal category and coaching do not identify a particular medicine

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

FDA: Drug Trials Snapshot, LynkuetChecked 2026-09-29

Original FDA approval and trial-population summary; not a complete current label or provider offering

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

DailyMed: Lynkuet elinzanetant capsulesChecked 2026-09-29

Exact current label revised August 2026; product-specific warnings and use, not a claim any reviewed clinic supplies it

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Wisp: Non-Hormonal Vaginal MoisturizerChecked 2026-09-29

Official specific local-dryness offer and latex-condom caution; marketing does not establish vasomotor efficacy or a complete formulation

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Wisp: Menopause Consult OnlineChecked 2026-09-29

Official clinical offer and separately billed local-pharmacy medicines; exact systemic nonhormonal medicine offer unconfirmed

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Wisp: terms of useChecked 2026-09-28

Dated platform transaction terms; prescription renewal review, 48-hour cancellation and discretionary product remedies; not individual legal advice

Read the original source ↗

Checked 2026-09-28. Labels and commercial information can change.

Joi + Blokes: Clinical care overviewChecked 2026-09-29

Official menopause clinical service and coaching roles; no specific nonhormonal vasomotor prescription confirmed

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Joi + Blokes: Hormone replacement therapyChecked 2026-09-29

Hormonal program prices and quarterly commitments; not a confirmed nonhormonal medicine menu or quote

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

FOLX: Perimenopause and menopause supportChecked 2026-09-29

Official LGBTQIA+ clinical service description with nonhormonal medication category; specific product and indication unconfirmed

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

FOLX: What can a clinician help with?Checked 2026-09-29

Official clinical service, published visit charges and appointment cancellation terms; not personal availability

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

FOLX: What is a membership?Checked 2026-09-29

Official membership explainer dated August 2023 as currently accessible; monthly versus annual billed amounts, services extra

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

FOLX: Membership cancellation policyChecked 2026-09-29

Official membership notice, annual account control timing, no membership refunds and remaining bills; separate appointment cancellation terms

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Maven: Hormone Care EssentialsChecked 2026-09-29

Direct clinical offer with stated nonhormonal medicine families and one-time care package; individual eligibility, selected drug and refund outcome unconfirmed

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Maven: Terms of UseChecked 2026-09-29

Official platform terms updated September 23, 2026; independent practitioner roles and enterprise distinctions, not a complete selected Hormone Care refund agreement

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Allara: menopause insurance landing pageChecked 2026-09-29

Service and plan-price record; broader Complete Care scope

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Allara: care program and service FAQsChecked 2026-09-29

Actual menopause care scope; state and program distinctions

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Allara help center: program costsChecked 2026-09-29

Official linked support record; self-pay, insurance and excluded charges

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Hello Alpha: menopause treatmentChecked 2026-09-29

Clinical service page; local estrogen and systemic nonhormonal categories need separation

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Mass General Brigham: Menopause and Midlife ClinicChecked 2026-09-29

Regional clinical program and appointment contacts; no exact drug menu verified

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Penn Medicine: menopause and postmenopause careChecked 2026-09-29

Clinical service; current new center focus on cancer survivors and previvors

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Myla Health: consultation servicesChecked 2026-09-29

UK private clinical service; NHS prescribing remains separate

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Myla Health: patient FAQsChecked 2026-09-29

UK location, billing, cancellation and investigation responsibility conditions

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Newson Clinic: consultationsChecked 2026-09-29

UK hormone and nonhormonal consultation scope; exact drug unconfirmed

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Newson Clinic: current services and displayed feesChecked 2026-09-29

Commercial service and fee record; no independent efficacy claim

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Hello Alpha: terms of useChecked 2026-09-29

Commercial terms; automatic renewal, separate refill cancellation and refund limits

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Hello Alpha: membershipChecked 2026-09-29

Published monthly plan and visit units; separate prescription charges

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Allara: terms and conditionsChecked 2026-09-29

Subscription cancellation and discretionary refund conditions; no legal advice

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Allara: how care worksChecked 2026-09-29

Broader weight-care page with different Complete Care and nutrition prices; selected quote unresolved

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Myla Health: prices effective April 1, 2026Checked 2026-09-29

UK visit and prescription-administration fees, excluding actual medicine

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Newson Clinic: prices-page extractionChecked 2026-09-29

Current extraction lacks a full fee table; home-page prices separately sourced

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Penn Medicine: contact and schedulingChecked 2026-09-29

Appointment contact hours; no personal availability or price established

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

The Menopause Society: 2023 nonhormone therapy position statementChecked 2026-09-29

Professional evidence review; predates Lynkuet approval

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

FDA: unapproved uses of approved drugsChecked 2026-09-29

Regulator explanation; product and indication scope

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

FDA: menopause treatment categoriesChecked 2026-09-29

Regulator patient overview; hormone versus nonhormone distinction

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

FDA: Lynkuet Drug Trials SnapshotChecked 2026-09-29

Original October 2025 approval evidence; current safety label separately reviewed

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Veozah (fezolinetant) US prescribing informationChecked 2026-09-29

Exact official DailyMed label. Revised February 2026; boxed hepatotoxicity warning; same-day official HTML record reviewed with original timestamp

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Lynkuet (elinzanetant) US prescribing informationChecked 2026-09-29

Exact official DailyMed label. Text revised August 2026; page metadata says updated June 16, 2026; same-day official HTML record reviewed with original timestamp

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Brisdelle (paroxetine) US prescribing informationChecked 2026-10-21

Exact official DailyMed label. Revised April 2025; exact 7.5 mg capsule, not general paroxetine tablets; same-day official HTML record reviewed with original timestamp

Read the original source ↗

Checked 2026-10-21. Labels and commercial information can change.

Duke Health — MenopauseChecked 2026-09-29

Official clinical service description, accessed September 29, 2026; an individual prescription, access arrangement, full price and outcome are not established. Published treatment categories are not an all-product formulary.

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Cleveland Clinic — Menopause TreatmentChecked 2026-09-29

Official clinical service description, accessed September 29, 2026; an individual prescription, access arrangement, full price and outcome are not established. Published treatment categories are not an all-product formulary.

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Mayo Clinic — Menopause and Women’s Sexual Health ClinicChecked 2026-09-29

Official clinical service description, accessed September 29, 2026; an individual prescription, access arrangement, full price and outcome are not established. Published treatment categories are not an all-product formulary.

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Johns Hopkins Medicine — Menopause ClinicChecked 2026-09-29

Official clinical service description, accessed September 29, 2026; an individual prescription, access arrangement, full price and outcome are not established. Published treatment categories are not an all-product formulary.

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Mount Sinai — MenopauseChecked 2026-09-29

Official clinical service description, accessed September 29, 2026; an individual prescription, access arrangement, full price and outcome are not established. Published treatment categories are not an all-product formulary.

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Northwestern Medicine — Program for MenopauseChecked 2026-09-29

Official clinical service description, accessed September 29, 2026; an individual prescription, access arrangement, full price and outcome are not established. Published treatment categories are not an all-product formulary.

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

UCLA Health — Comprehensive Menopause Program Clinical ServicesChecked 2026-09-29

Official clinical service description, accessed September 29, 2026; an individual prescription, access arrangement, full price and outcome are not established. Published treatment categories are not an all-product formulary.

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Stanford Health Care — Menopause TreatmentsChecked 2026-09-29

Official clinical service description, accessed September 29, 2026; an individual prescription, access arrangement, full price and outcome are not established. Published treatment categories are not an all-product formulary.

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

University of Utah Health — Midlife Women’s Health and Menopause ProgramChecked 2026-09-29

Official clinical service description, accessed September 29, 2026; an individual prescription, access arrangement, full price and outcome are not established. Published treatment categories are not an all-product formulary.

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Mount Sinai — Menopause LocationsChecked 2026-09-29

Official clinical location or appointment information, accessed September 29, 2026; regional access and preparation are distinct from medicine eligibility or monitoring.

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

Northwestern Medicine — Center for Sexual Medicine and MenopauseChecked 2026-09-29

Official clinical location or appointment information, accessed September 29, 2026; regional access and preparation are distinct from medicine eligibility or monitoring.

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

UCLA Health — Comprehensive Menopause Program Patient InformationChecked 2026-09-29

Official clinical location or appointment information, accessed September 29, 2026; regional access and preparation are distinct from medicine eligibility or monitoring.

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

University of Utah Health — What to Expect at Your Midlife AppointmentChecked 2026-09-29

Official clinical location or appointment information, accessed September 29, 2026; regional access and preparation are distinct from medicine eligibility or monitoring.

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

The 2023 nonhormone therapy position statement of The North American Menopause Society — PubMed abstractChecked 2026-09-29

Primary professional position-statement abstract, published 2023; vasomotor-symptom scope only. Full article not retrieved. Predates later drug approvals; does not evaluate these clinics or equate all forms of counseling.

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

FDA — Fezolinetant serious liver-injury safety communicationChecked 2026-09-29

Federal primary safety communication; the retrieved text displays the September 12, 2024 communication. Used for serious liver-risk and testing context only; current boxed warning and contraindications are separately supported by the current exact DailyMed label where discussed.

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

FDA — Hormone Replacement Therapies Can Help Women with Bothersome Menopausal SymptomsChecked 2026-09-29

Current federal consumer overview, accessed September 29, 2026; confirms multiple approved nonhormonal therapies. Not a clinic’s formulary, a treatment protocol or proof all requested hormone-label changes are completed.

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

DailyMed — VEOZAH fezolinetant tablet, Astellas Pharma USChecked 2026-10-21

Exact oral product prescribing information, revised February 2026; boxed hepatotoxicity warning, all three contraindications and testing duties remain product-specific. Not evidence of individual clinic prescribing or a personal monitoring schedule.

Read the original source ↗

Checked 2026-10-21. Labels and commercial information can change.

DailyMed — LYNKUET elinzanetant capsule, Bayer HealthCare PharmaceuticalsChecked 2026-09-29

Exact oral product prescribing information, internally revised August 2026 including seizure warning; displayed page update metadata June 16, 2026 is distinct. Indication and safety context only, not evidence UCLA offers this product. No insomnia approval or personal plan inferred.

Read the original source ↗

Checked 2026-09-29. Labels and commercial information can change.

CoreAge Rx: shipping reference and service detailsChecked 2026-10-12

Homepage shipping reference; customer service and payment details supplied for this review, without a checkout or timed support test

Read the original source ↗

Checked 2026-10-12. Labels and commercial information can change.

Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials.Checked 2026-10-21

Indexed primary study abstract

Read the original source ↗

Checked 2026-10-21. Labels and commercial information can change.

Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause.Checked 2026-10-21

Indexed primary study abstract and full research article

Read the original source ↗

Checked 2026-10-21. Labels and commercial information can change.

Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study.Checked 2026-10-21

Indexed primary study abstract

Read the original source ↗

Checked 2026-10-21. Labels and commercial information can change.

Gennev: careChecked 2026-11-10

Provider service information

Read the original source ↗

Checked 2026-11-10. Labels and commercial information can change.

Gennev: feesChecked 2026-11-10

Provider pricing

Read the original source ↗

Checked 2026-11-10. Labels and commercial information can change.

Gennev: termsChecked 2026-11-10

Provider terms

Read the original source ↗

Checked 2026-11-10. Labels and commercial information can change.

Gennev: weight careChecked 2026-11-10

Provider service information

Read the original source ↗

Checked 2026-11-10. Labels and commercial information can change.

DailyMed: LynkuetChecked 2026-11-10

Exact product labeling

Read the original source ↗

Checked 2026-11-10. Labels and commercial information can change.

DailyMed: VeozahChecked 2026-11-10

Exact product labeling

Read the original source ↗

Checked 2026-11-10. Labels and commercial information can change.

DailyMed: BrisdelleChecked 2026-11-10

Exact product labeling

Read the original source ↗

Checked 2026-11-10. Labels and commercial information can change.

Newson: feesChecked 2026-11-10

Provider pricing

Read the original source ↗

Checked 2026-11-10. Labels and commercial information can change.

Newson: termsChecked 2026-11-10

Provider terms

Read the original source ↗

Checked 2026-11-10. Labels and commercial information can change.

Newson: consultationsChecked 2026-11-10

Provider service information

Read the original source ↗

Checked 2026-11-10. Labels and commercial information can change.

Evernow: paroxetineChecked 2026-11-10

Provider product information

Read the original source ↗

Checked 2026-11-10. Labels and commercial information can change.

Evernow: VeozahChecked 2026-11-10

Provider product information

Read the original source ↗

Checked 2026-11-10. Labels and commercial information can change.

Evernow: FAQChecked 2026-11-10

Provider service information

Read the original source ↗

Checked 2026-11-10. Labels and commercial information can change.

CoreAge: offerChecked 2026-11-10

Provider product information

Read the original source ↗

Checked 2026-11-10. Labels and commercial information can change.

Midi: feesChecked 2026-11-10

Provider pricing

Read the original source ↗

Checked 2026-11-10. Labels and commercial information can change.